Heart failure incidence rates decreased by 17% in the 2019–2023 cohort compared to 2014–2018 (IRR 0.834; 95% CI 0.743-0.936), alongside improved survival rates.
Cohort (n=6,965)
Yes
Heart failure incidence declined by 17% between 2014-2018 and 2019-2023 in a central Italian population, accompanied by improvements in short- and long-term survival.
Effect estimate: IRR 0.834 (95% CI 0.743-0.936)
Objective Heart failure (HF) is a major public health issue due to its high morbidity, mortality and healthcare burden. This study aimed to provide estimates of HF incidence, survival rates, outcome changes and their predictive factors in a central Italian population over the decade 2014–2023. Design Population-based retrospective cohort study. Setting Hospital discharge records from all hospitals in L'Aquila Province of Italy were analysed. Participants All residents who experienced a HF index hospitalisation between 2014 and 2023 were included. HF index hospitalisation was defined as the first hospitalisation for HF in patients with no prior hospitalisation from the same diagnosis for at least 4 years. Primary outcome measures The primary outcomes were age-standardised and sex-standardised incidence rates of HF index hospitalisations and all-cause mortality following index hospitalisation. Incidence rate ratios (IRRs), survival and their associated factors were analysed with negative binomial regression models, Kaplan-Meier analysis and Cox proportional hazards models, respectively. Results A total of 6965 incident cases from 17 588 HF hospitalisations in the decade under study were analysed. The overall standardised incidence rate was 1.73 per 1000 person-years, with significant differences by age and sex. Incidence rates decreased by 17% from 2014–2018 to 2019–2023 (IRR: 0.834; 95% CI 0.743 to 0.936). Cumulative 1-year and 5-year survival were 70.05% and 36.38%, respectively, with a progressively higher mortality risk in older people. Compared with the 2014–2018 cohort, the 2019–2022 cohort showed improved survival at 30 and 90 days and at 1 year overall and by age groups, with <50 exception. Conclusions HF incidence declined, particularly in older populations, and remained higher in men, while survival rates improved. Despite these trends, HF continues to represent a substantial clinical and public health burden.
Lancia et al. (Wed,) conducted a cohort in Heart failure (n=6,965). 2019-2023 cohort vs. 2014-2018 cohort was evaluated on Age-standardised and sex-standardised incidence rates of HF index hospitalisations and all-cause mortality following index hospitalisation (IRR 0.834, 95% CI 0.743-0.936). Heart failure incidence rates decreased by 17% in the 2019–2023 cohort compared to 2014–2018 (IRR 0.834; 95% CI 0.743-0.936), alongside improved survival rates.